MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

: LV5FU2 Therapie - Phase 2 (Zyklen 7-12)

Raw xml | Download


<Procedure xmlns="http://hl7.org/fhir">
  <id value="mii-exa-onko-lv5fu2-phase2"/>
  <meta>
    <profile
             value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-systemische-therapie"/>
  </meta>
  <language value="de"/>
  <text>
    <status value="extensions"/>
    <div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: Procedure mii-exa-onko-lv5fu2-phase2</b></p><a name="de-mii-exa-onko-lv5fu2-phase2"> </a><a name="de-hcmii-exa-onko-lv5fu2-phase2"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mii-pr-onko-systemische-therapie.html">MII PR Onkologie Systemische Therapie</a></p></div><p><b>MII EX Onko Systemische Therapie Intention</b>: <span title="Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-intention K}">Kurativ</span></p><p><b>MII EX Onko Systemische Therapie Stellung zur OP</b>: <span title="Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-stellungzurop A}">Adjuvant</span></p><p><b>basedOn</b>: <a href="CarePlan-mii-exa-onko-tumorkonferenz-folfox-modification.html">CarePlan: identifier = Tumorkonferenz_FOLFOX_Modification_001; status = active; intent = plan; category = prätherapeutische Tumorkonferenz (Festlegung der Therapiestrategie); created = 2024-03-05</a></p><p><b>partOf</b>: <a href="Procedure-mii-exa-onko-folfox-phase1.html">Procedure Nicht komplexe Chemotherapie</a></p><p><b>status</b>: Completed</p><p><b>category</b>: <span title="Codes:{http://snomed.info/sct 18629005}">Administration of medication</span></p><p><b>code</b>: <span title="Codes:{http://fhir.de/CodeSystem/bfarm/ops 8-542}, {https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-systemische-therapie-art CH}">Nicht komplexe Chemotherapie</span></p><p><b>subject</b>: <a href="Patient-example-modification.html">Martin Beispiel  Male, DoB: 1958-11-03</a></p><p><b>encounter</b>: <a href="Encounter-example-chemo-phase2.html">Encounter: status = finished; class = ambulatory (ActCode#AMB)</a></p><p><b>performed</b>: 2024-06-17 --&gt; 2024-09-10</p><p><b>reasonReference</b>: <a href="Condition-mii-exa-onko-ascending-colon-cancer-diagnosis.html">Condition Bösartige Neubildung: Colon ascendens</a></p><p><b>outcome</b>: <span title="Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-ende-grund E}">Reguläres Ende</span></p><p><b>note</b>: </p><blockquote><div><p>Modified protocol: LV5FU2 (5-FU/Leucovorin) for cycles 7-12. Oxaliplatin omitted due to persistent neuropathy. Patient tolerated modified regimen well. Completed all planned cycles.</p>
</div></blockquote><p><b>usedCode</b>: <span title="Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-systemische-therapie-protokolle LV5FU2}">LV5FU2</span></p></div>
  </text>
  <extension
             url="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-ex-onko-systemische-therapie-intention">
    <valueCodeableConcept>
      <coding>
        <system
                value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-intention"/>
        <code value="K"/>
        <display value="Kurativ"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <extension
             url="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-ex-onko-systemische-therapie-stellungzurop">
    <valueCodeableConcept>
      <coding>
        <system
                value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-stellungzurop"/>
        <code value="A"/>
        <display value="Adjuvant"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <basedOn>🔗 
    <reference
               value="CarePlan/mii-exa-onko-tumorkonferenz-folfox-modification"/>
  </basedOn>
  <partOf>🔗 
    <reference value="Procedure/mii-exa-onko-folfox-phase1"/>
  </partOf>
  <status value="completed"/>
  <category>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="18629005"/>
    </coding>
  </category>
  <code>
    <coding>
      <system value="http://fhir.de/CodeSystem/bfarm/ops"/>
      <version value="2024"/>
      <code value="8-542"/>
      <display value="Nicht komplexe Chemotherapie"/>
    </coding>
    <coding>
      <system
              value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-systemische-therapie-art"/>
      <code value="CH"/>
      <display value="Chemotherapie"/>
    </coding>
  </code>
  <subject>🔗 
    <reference value="Patient/example-modification"/>
  </subject>
  <encounter>🔗 
    <reference value="Encounter/example-chemo-phase2"/>
  </encounter>
  <performedPeriod>
    <start value="2024-06-17"/>
    <end value="2024-09-10"/>
  </performedPeriod>
  <reasonReference>🔗 
    <reference
               value="Condition/mii-exa-onko-ascending-colon-cancer-diagnosis"/>
  </reasonReference>
  <outcome>
    <coding>
      <system
              value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-ende-grund"/>
      <code value="E"/>
      <display value="Reguläres Ende"/>
    </coding>
  </outcome>
  <note>
    <text
          value="Modified protocol: LV5FU2 (5-FU/Leucovorin) for cycles 7-12. Oxaliplatin omitted due to persistent neuropathy. Patient tolerated modified regimen well. Completed all planned cycles."/>
  </note>
  <usedCode>
    <coding>
      <system
              value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-systemische-therapie-protokolle"/>
      <code value="LV5FU2"/>
      <display value="LV5FU2"/>
    </coding>
  </usedCode>
</Procedure>